Popular:
Johnson & Johnson (JNJ)
Intrinsic Value (DCF)
Current$213.65
→
Intrinsic$154.34
-28%
$101.87$154.34$258.78
Market implies 16% growth for 5 years
JNJ trades at a premium to our conservative estimate — investors expect above-average performance.
At $214, the market prices in continued high-teens cash flow growth (16%) — likely reflecting buybacks, margin stability, and ecosystem strength.
Range: Bear $102 → Bull $259. Current price implies expectations above the base case, closer to bull expectations.
| Discount ↓Growth → | 4% | 6% | 8% | 10% |
|---|---|---|---|---|
| 8% | $190 | $208 | $227 | $248 |
| 10% | $129 | $141 | $154 | $168 |
| 12% | $98 | $106 | $116 | $126 |
| 14% | $78 | $85 | $92 | $100 |
Bull Case
- Bull case ($259) offers 21% upside at 10% growth, 8% discount
- Conservative 8% growth assumption is achievable based on track record
Bear Case
- Bear case ($102) implies 52% downside at 6% growth, 12% discount
- Price reflects 16% growth expectations vs 8% historical — high bar to clear
- Trading 28% above base case — execution must exceed assumptions to justify
Loading charts...
5-Year Free Cash Flow Projection
Year 1$21.43B
Year 2$23.14B
Year 3$25.00B
Year 4$26.99B
Year 5$29.15B
Terminal$461.99B
📐 Model Inputs
Growth Rate8.0%5Y CAGR (cascade: 5Y→3Y→TTM)
Discount Rate9.5%WACC estimate
Terminal Growth3.0%Perpetuity rate
Base Free Cash Flow$19.84BTTM actual
Bear g×0.8, r+2%
Base Historical CAGR
Bull g×1.2, r−1.5%
DCF estimates based on historical growth rates extrapolated forward. See FAQ below for full methodology.